Cardiac glycosides and COVID-19: would it be a promising therapeutic approach?
- PMID: 33146236
- DOI: 10.1590/0001-3765202020201080
Cardiac glycosides and COVID-19: would it be a promising therapeutic approach?
Abstract
Cardiac glycosides have been found to have an anti-viral effect. This was noted in the past during various epidemics including MERS and SARS. It is due to their inhibitory effect on the Na, K-ATPase membrane pump. Furthermore, they exhibit anti-inflammatory properties. These preclinical observations may prove useful in further clinical utility of these well-known compounds in the current COVID-19 pandemic.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous